We Have Exciting News! RLS Radiopharmacies Has Entered into an Agreement To Be Acquired by Telix Pharmaceuticals!
We are excited to announce that RLS Radiopharmacies, America’s only Joint Commission-accredited nationwide radiopharmacy network distributing PET, SPECT, and therapeutic radiopharmaceuticals, has entered into an agreement to be acquired by Telix Pharmaceuticals Limited (ASX: TLX). Telix is a global radiopharmaceutical company focused on the development and commercialization of therapeutic and […]
Read More